Blog Posts
Agenus Thanks ESMO and Ben Schlechter for Sharing the New Data of BOT/BAL in Refractory MSS CRC
dana-farber.org

Agenus Thanks ESMO and Ben Schlechter for Sharing the New Data of BOT/BAL in Refractory MSS CRC

Agenus shared on LinkedIn:

“Thank you to ESMO – European Society for Medical Oncology-GI and Dr. Ben Schlechter of Dana-Farber Cancer Institute for sharing the new data of BOT/BAL in refractory MSS colorectal cancer.”

More posts about ESMOGI25.

Agenus Ben Schlechter cancer colorectal cancer CRC ESMO-GI OncoDaily Oncology